Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Genentech is recalling Susvimo ocular implants (452 units nationwide) due to manufacturing defects in the drug delivery system. A few patients have experienced non-functioning implants.
Golden State Medical Supply Inc. is recalling 2,584 bottles of Atenolol 25mg tablets nationwide. Bottles labeled as Atenolol 25mg actually contain Clopidogrel 75mg tablets—a different medication.
Exela Pharma Sciences is recalling 2,123,040 vials of Sodium Bicarbonate 8.4% Injection due to container defects causing vial breakage and glass release when pressurized during product preparation.
Nationwide recall of 8.4% sodium bicarbonate injection vials due to container defects causing vial breakage and glass fragments when pressurized during preparation.
AuroMedics Pharma LLC is recalling 11,520 units of Fondaparinux Sodium Injection nationwide due to out-of-specification potency. Patients should contact their healthcare provider immediately.
Aurobindo Pharma USA Inc. is recalling Quinapril/Hydrochlorothiazide Tablets 20mg/12.5mg due to N-nitroso-quinapril impurity above acceptable limits from manufacturing deviations. Affected lots QE2021005-A and QE2021010-A were distributed nationwide.
Ultra Chem Labs Corp is recalling Proton Armor Anti-Microbial Alcohol-Free Foaming Hand Sanitizer nationwide due to trace amounts of methanol found in product components during manufacturing. The recall affects multiple bottle sizes with batch number 20117206.
Ultra Chem Labs Corp is recalling Proton Armor hand sanitizer nationwide due to trace amounts of methanol found in a manufacturing component. No illnesses have been reported.
VistaPharm recalls 1980 unit-dose cups of pyridostigmine bromide oral solution due to a preservative ingredient found out of specification during quality control. Lot 832400, nationwide distribution.
Golden State Medical Supply Inc. is recalling Rifampin Capsules, USP, 300 mg, because samples exceeded acceptable limits for 1-Methyl-4-Nitrosopoperazine (MNP), an impurity. Multiple lot numbers were distributed nationwide.
Fresenius Medical Care is recalling 0.9% Sodium Chloride Injection distributed nationwide due to lack of assurance of sterility and potential leakage. Multiple lot numbers with expiration dates ranging from May 2023 to August 2023 are affected.
AuroMedics Pharma is recalling Acyclovir Sodium injection due to dark red, brown, and black particulate matter found in vials. Approximately 89,400 vials were distributed nationwide.
Walgreens Sinus Pressure, Pain & Cough tablets are mislabeled as 'Decongestant Free' but contain Phenylephrine HCl, a nasal decongestant. The labeling error affects 66,384 boxes distributed nationwide.
Ingenus Pharmaceuticals is recalling Flunisolide Nasal Solution nationwide because the product contains impurities that exceed acceptable limits. The recall affects two lots distributed across the United States.
Golden State Medical Supply Inc. is recalling Rifampin Capsules, 150 mg, due to elevated levels of 1-Methyl-4-Nitrosopiperazine (MNP) exceeding the FDA interim specification limit of 5 ppm. Affected lots are distributed nationwide.
Justified Laboratories is recalling Skincell Mole & Skin Corrector Serum because it was marketed without FDA approval. The affected product was distributed throughout the United States, Puerto Rico, and Canada.
Justified Laboratories is recalling Skincell Mole & Skin Corrector Serum. The product was marketed as a drug without FDA approval (NDA/ANDA).
Pfizer is recalling Aminophylline Injection vials due to a complaint of particulate matter (hair) in one vial. Over 103,000 vials were distributed to the US and Puerto Rico.
Pending LLM rewrite. Source: FDA_DRUG D-0007-2023.
Cipla recalls Arformoterol Tartrate Inhalation Solution due to environmental monitoring failure affecting sterility assurance.
Pending LLM rewrite. Source: FDA_DRUG D-0002-2023.
Pending LLM rewrite. Source: FDA_DRUG D-1551-2022.
Salon Technologies International is recalling Sanitizing Hand Spray 80% due to GMP deviations: the product contains acetaldehyde and acetal above specification limits. The recall affects 1,656 bottles distributed in Florida and Washington.
Woodbine Products is recalling FOAMFRESH DYE FREE ANTIBACTERIAL HAND WASH due to incorrect scent information on the label. The affected lots VDAF017 and VDAF018 were distributed in North Carolina, and no illnesses have been reported.
Akorn, Inc. is recalling 18,145 bottles of Rifampin Capsules, USP 150 mg due to impurity levels exceeding the FDA's 5 ppm interim specification limit for 1-Methyl-4-Nitrosopiperazine (MNP).